why is compounded tirzepatide still being sold Compounding pharmacies can resume making

Nat Rev Drug Discov 8:500515 Kooij KL, Koster DIj, Eeltink E et al (2024) GLP-1 receptor agonist semaglutide reduces appetite while increasing dopamine reward signaling

Clinical trials running up to 72 weeks have shown a manageable safety profile with primarily GI-related side effects

It's kind of surreal how well this works. Alexander M

FDA Approvals for Tirzepatide (Including Mounjaro and Zepbound) The FDA has granted approval for tirzepatide for two distinct but related conditions, marketed under two different brand names

Some researchers find that starting at even lower doses than the clinical trial protocols and escalating more slowly can reduce the severity of gastrointestinal symptoms

Quick is better